← back to search

Emily A. Blumberg

National Institute of Allergy and Infectious Diseases · US
Area of research
Transplantation · Epidemiology
Research interest
Research interests include Renal Transplantation Outcomes and Treatments, Cytomegalovirus and herpesvirus research, Hepatitis C virus research, and Transplantation: Methods and Outcomes.
h-index
62
citations
15,691
works
336
NIH funding
primary concept
Medicine
email

Recent publications

Kaposi Sarcoma–Associated Herpesvirus Risk and Disease in Kidney Donors and Transplant Recipients With HIV in the United States
Clinical Infectious Diseases 2025cited by 8position: middledoi
Safety of Kidney Transplantation from Donors with HIV
New England Journal of Medicine 2024cited by 48position: middledoi
Infection and clinical xenotransplantation: Guidance from the Infectious Disease Community of Practice of the American Society of Transplantation
American Journal of Transplantation 2023cited by 45position: middledoi
Wait Time Advantage for Transplant Candidates With HIV Who Accept Kidneys From Donors With HIV Under the HOPE Act
Transplantation 2023cited by 30position: middledoi
Age‐related decline in anti‐HBV antibodies in vaccinated kidney transplant recipients
Transplant Infectious Disease 2023cited by 1position: middledoi
Delayed Mortality Among Solid Organ Transplant Recipients Hospitalized for COVID-19
Clinical Infectious Diseases 2022cited by 14position: middledoi
The effect of induction immunosuppression for kidney transplant on the latent HIV reservoir
JCI Insight 2022cited by 13position: middledoi
Maribavir for Refractory Cytomegalovirus Infections With or Without Resistance Post-Transplant: Results From a Phase 3 Randomized Clinical Trial
Clinical Infectious Diseases 2021cited by 293position: middledoi
American Association for the Study of Liver Diseases Expert Panel Consensus Statement: Vaccines to Prevent Coronavirus Disease 2019 Infection in Patients With Liver Disease
Hepatology 2021cited by 155position: middledoi
Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic
American Journal of Transplantation 2021cited by 78position: middledoi
COVID-19 in hospitalized lung and non-lung solid organ transplant recipients: A comparative analysis from a multicenter study
American Journal of Transplantation 2021cited by 54position: middledoi
Impact of pre‐transplant carbapenem‐resistant <i>Enterobacterales</i> colonization and/or infection on solid organ transplant outcomes
Clinical Transplantation 2021cited by 29position: middledoi
National Landscape of Human Immunodeficiency Virus–Positive Deceased Organ Donors in the United States
Clinical Infectious Diseases 2021cited by 22position: middledoi
One-Year Outcomes of the Multi-Center StudY to Transplant Hepatitis C-InfeCted kidneys (MYTHIC) Trial
Kidney International Reports 2021cited by 20position: middledoi
Association of donor hepatitis C virus infection status and risk of BK polyomavirus viremia after kidney transplantation
American Journal of Transplantation 2021cited by 18position: middledoi
Proceedings from the metrics forum in heart transplantation for performance monitoring
American Journal of Transplantation 2021cited by 8position: middledoi
Coronavirus Disease 2019 in Solid Organ Transplant: A Multicenter Cohort Study
Clinical Infectious Diseases 2020cited by 405position: middledoi
Clarifying the HOPE Act landscape: The challenge of donors with false-positive HIV results
American Journal of Transplantation 2019cited by 16position: middledoi
Letermovir Prophylaxis for Cytomegalovirus in Hematopoietic-Cell Transplantation
New England Journal of Medicine 2017cited by 1,192position: middledoi
Perioperative Antibiotic Prophylaxis to Prevent Surgical Site Infections in Solid Organ Transplantation
Transplantation 2017cited by 118position: middledoi
Use of Viral Load as a Surrogate Marker in Clinical Studies of Cytomegalovirus in Solid Organ Transplantation: A Systematic Review and Meta-analysis
Clinical Infectious Diseases 2017cited by 95position: middledoi
Solid Organ Transplantation From Hepatitis B Virus–Positive Donors: Consensus Guidelines for Recipient Management
American Journal of Transplantation 2015cited by 243position: middledoi
Survival in HIV-positive transplant recipients compared with transplant candidates and with HIV-negative controls
AIDS 2015cited by 85position: middledoi
Cryptococcosis in Patients With Cirrhosis of the Liver and Posttransplant Outcomes
Transplantation 2015cited by 50position: middledoi
Considerations for Screening Live Kidney Donors for Endemic Infections: A Viewpoint on the UNOS Policy
American Journal of Transplantation 2014cited by 58position: lastdoi
Communication Gaps Associated With Donor-Derived Infections
American Journal of Transplantation 2014cited by 43position: lastdoi
Long-term management of the successful adult liver transplant: 2012 practice guideline by the American Association for the Study of Liver Diseases and the American Society of Transplantation
Liver Transplantation 2012cited by 543position: middledoi
Diagnosis and Management of Tuberculosis in Transplant Donors: A Donor-Derived Infections Consensus Conference Report
American Journal of Transplantation 2012cited by 145position: middledoi
Efficacy and Safety of Maribavir Dosed at 100 mg Orally Twice Daily for the Prevention of Cytomegalovirus Disease in Liver Transplant Recipients: A Randomized, Double-Blind, Multicenter Controlled Trial
American Journal of Transplantation 2012cited by 137position: middledoi
Infections and Organ Transplantation
Transplantation 2012cited by 32position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Deepali Kumar · University Health Network3 papers (2012–2021)Daniel Kaul · Michigan Medicine3 papers (2014–2021)Michael G. Ison · Development Services Group (United States)3 papers (2012–2014)Michele I. Morris · University of Miami3 papers (2012–2015)Robin K. Avery · Atotech (United States)3 papers (2012–2021)Shirish Huprikar · Optech (Canada)3 papers (2015–2021)M. Green · University of Pittsburgh2 papers (2014–2014)Meghan E. Sise · Columbia University2 papers (2021–2021)Peter P. Reese · Pennsylvania Hospital2 papers (2021–2021)Robert J. Fontana · University of Edinburgh2 papers (2021–2021)Roy F. Chemaly · The University of Texas MD Anderson Cancer Center2 papers (2017–2021)Rachel Miller · University of Iowa2 papers (2014–2015)Marian G. Michaels · University of Pittsburgh2 papers (2012–2014)Rafael F. Duarte · Hospital Universitario Puerta de Hierro Majadahonda2 papers (2017–2021)Ian A. Strohbehn · University of Vermont2 papers (2021–2021)Johan Maertens · Ospedale Policlinico San Martino2 papers (2017–2021)Fernanda P. Silveira · University of Pittsburgh Medical Center2 papers (2015–2021)David S. Goldberg · University of Miami2 papers (2021–2021)Francisco M. Marty · Dana-Farber Cancer Institute2 papers (2017–2021)Douglas E. Schaubel · Institute for Medical Informatics and Biostatistics2 papers (2021–2021)